Theranexus SA (3VG) Stock Statistics & Valuation Metrics

Theranexus SA has a market cap or net worth of €6.95M. The enterprise value is €12.09M.

Theranexus SA has 7,758,724 shares outstanding. The number of shares has decreased by -2.65% in one year.

Theranexus SA’s return on equity (ROE) is -3.07 and return on invested capital (ROIC) is -116.64%.

The current PE Ratio of Theranexus SA is -1.27. Theranexus SA’s PEG ratio is 0.06.

In the last 12 months, Theranexus SA had revenue of 296.33K and earned -6.83M in profits. Earnings per share was -0.88.

In the last 12 months, operating cash flow was -4.83M and capital expenditures -5.17K, giving a free cash flow of -4.83M billion.

Theranexus SA pays an annual dividend of ―, resulting in a dividend yield of ―

Theranexus SA upcoming earnings date is Sep 25, 2025, TBA Not Confirmed.

Theranexus SA as a current ratio of 2.34, with Debt / Equity ratio of 85.35%

In the past 12 months, Theranexus SA has paid -801.84K in taxes.

Theranexus SA EV to EBITDA ratio is -1.51, with an EV/FCF ratio of -1.74.

Theranexus SA has €1.75M in cash and marketable securities with €2.94M in debt, giving a net cash position of €1.18M billion.

Gross margin is 19.98%, with operating margin of -2579.44%, and net profit margin of -2304.16%.

The average price target for Theranexus SA is ―, which is 11.43% higher than the current price. The consensus rating is ―